11/22/2023 0 Comments Sequential leg compression machineTraditionally, physicians’ orders for SCD or other types of mechanical compression therapy have lacked all the components needed to provide adequate therapy. (Be aware, though, that SCD therapy is contraindicated in DVT, compartment syndrome, extremity deformity, and an open infected wound of the extremity.) These methods are as efficacious and reduce risk as much as pharmacologic methods, without causing bleeding complications. Mechanical devices, such as SCDs, are the first choice for VTE prophylaxis. Those with cancer, trauma, surgery, and obstetric diagnoses have the highest risk for VTE complications. Hospital patients are at higher risk for VTE because of their limited mobility, active disease processes, and comorbidities. This is best achieved through risk stratification, identification of at-risk patients, and use of VTE prophylaxis (pharmacologic, mechanical, or a combination). To enhance patient outcomes, clinicians should focus on VTE prevention. Enhancing patient outcomes with sequential compression device therapy The chart describes these factors and the conditions that can cause them. Three broad categories of factors in the image below, known as Virchow’s triad, contribute to VTE. DVT risk increases with damage or trauma to the venous system or the lungs and with patient immobility. One-way venous valves open in response to pressure of the blood to prevent backward flow and blood pooling in the venous system. This occurs because the venous system is a low-pressure system muscles act as pumps to increase the velocity of returning blood, forcing blood upward to the heart. Contractions of leg muscles and one-way venous valves push blood forward from the feet to the heart’s right atrium. The deep veins in the legs return venous blood to the right atrium and lungs. With PE, mortality can be as high as 25% the condition causes roughly 10% to 25% of hospital deaths. Mortality for lower-extremity DVT ranges from 13% to 21% for upper-extremity DVT, it may be as high as 48%. With today’s shorter hospital stays and more same-day surgeries, patients with DVT may lack symptoms while hospitalized or may not develop symptoms until after discharge. Incidence of upper-extremity DVT has risen from increasing use of indwelling venous access catheters, permanent pacemakers, and internal cardiac defibrillators. Venous thromboembolism (VTE) is the umbrella term for DVT and PE. In the lung, the clot inhibits blood flow and can damage part of the lung or even lead to death. It can lead to pulmonary embolism (PE), in which the clot breaks loose, travels through the bloodstream to the lungs, and lodges there. DVT results from clot formation in a deep vein, usually in the leg. More than 2.5 million people are diagnosed with deep vein thrombosis (DVT) each year. (See Understanding venous thromboembolism.) Understanding venous thromboembolism The Joint Commission now uses the term venous thromboembolism (VTE) to encompass both DVT and PE. As a nurse, you can play a pivotal role in improving outcomes by evaluating patients at risk for deep vein thrombosis (DVT) and by using SCD properly and safely to prevent complications of thrombi and pulmonary embolism (PE). Patients continue to have poor outcomes after suffering blood clots in the legs or arms, despite physician orders for therapy with sequential compression devices (SCDs). Author Guidelines and Manuscript Submission.The tubeless design provides convenient at-home therapy, improving the patient experience. Provides an alternative to additional pharmaceuticals that doctors can prescribe post-operatively.Helps prevent onset deep vein thrombosis after orthopedic surgery with intermittent compression.The device has two LCD screens to monitor usage and pressure.Īdditional medical benefits of compression therapy:.The device has two modes including slow inflation or Step-Up Technology allowing the unit to increase pressure in slower increments. There are two compression modes helping accommodate the recovery of different patients.This is why this device uses a long-lasting, rechargeable battery and can operate for up to 10 hours on one charge. This is a tubeless device and made to be portable.This compression system is portable, lightweight, and tubeless with the ability to treat patients in a clinical or home setting.This device promotes patient portability and ease: The PlasmaFlow is tubeless allowing the patient to recover from anywhere. By simulating muscle contractions blood flow, the risk for DVT decreases. This device helps prevent the onset of DVT in patients by stimulating blood flow in the extremities. The PlasmaFlow is an easy-to-use sequential compression system that can be used at home or in a clinical setting. PlasmaFlow: Sequential Compression SKU: E0676
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |